Human Brain Sequential Extraction (Tau)

By Michael Henderson, PhD
View Published Protocol

Output Details

Description
This protocol details human brain sequential extraction for pathological tau. This protocol is an adaptation of the work of several labs.
Identifier (DOI)
10.17504/protocols.io.q26g7p9y8gwz/v1
Tags
  • Biochemistry
  • Brain
  • Extraction
  • Human
  • In Vitro
  • Phosphorylated tau
  • Postmortem
Team
Team Biederer
Program
Collaborative Research Network
Theme
Circuitry and Brain-Body Interactions

Meet the Authors

Related Research

LRRK2 kinase inhibition reverses G2019S mutation-dependent effects on tau pathology spread

Mutations in LRRK2 are the most common cause of familial Parkinson’s disease. This work supports a protective role of LRRK2 kinase inhibition in G2019S carriers and provides a workflow for systematic evaluation of brain-wide phenotypes

View Article

End-product inhibition of the LRRK2-counteracting PPM1H phosphatase

PPM1H phosphatase reverses Rab GTPase phosphorylation by LRRK2 in Parkinson's disease. PPM1H binds Rab8A and Rab10 at an allosteric site, inhibiting phosphatase activity. Targeting this site may offer a therapeutic strategy.

View Article

Microscopy-based bead protein-protein interaction assay.

Protocol for microscopy-based bead protein-protein interaction assay using GST- or mCherry-tagged baits and fluorescently-tagged preys. Requires purified proteins, monitors interactions in equilibrium, and allows quantification of fluorescent signal.

View Protocol
View More Outputs